The present invention relates to pyrazolopyrimidine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
-
Page/Page column 60
(2016/09/26)
More Articles about upstream products of 536718-30-6